Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Nichols

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocolC R Nichols, J Andersen, H M Lazarus, et al.
Cancer Research|July 1, 1989
Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activityG J Tricot, H N Jayaram, E Lapis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup StudyC R Nichols, B J Roth, S D Williams, et al.
Cancer|March 15, 1994
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow supportE R Broun, C R Nichols, M Turns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trialD F Bajorin, C R Nichols, H J Schmoll, et al.
Epidemiology and Infection|November 1, 2000
The pandemic of Salmonella enteritidis phage type 4 reaches Utah: a complex investigation confirms the need for continuing rigorous control measuresJ Sobel, A B Hirshfeld, K McTigue, et al.
Experimental Hematology|August 1, 1990
Characteristics of engraftment after repeated autologous bone marrow transplantationK van Besien, C R Nichols, G Tricot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumorsJ T Hartmann, C R Nichols, J-P Droz, et al.
Cancer|June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantationC R Nichols, G Tricot, S D Williams, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocolC R Nichols, J Andersen, H M Lazarus, et al.
Cancer Research|July 1, 1989
Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activityG J Tricot, H N Jayaram, E Lapis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup StudyC R Nichols, B J Roth, S D Williams, et al.
Cancer|March 15, 1994
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow supportE R Broun, C R Nichols, M Turns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trialD F Bajorin, C R Nichols, H J Schmoll, et al.
Epidemiology and Infection|November 1, 2000
The pandemic of Salmonella enteritidis phage type 4 reaches Utah: a complex investigation confirms the need for continuing rigorous control measuresJ Sobel, A B Hirshfeld, K McTigue, et al.
Experimental Hematology|August 1, 1990
Characteristics of engraftment after repeated autologous bone marrow transplantationK van Besien, C R Nichols, G Tricot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumorsJ T Hartmann, C R Nichols, J-P Droz, et al.
Cancer|June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantationC R Nichols, G Tricot, S D Williams, et al.
Pageof 11